Hair shaft abnormalities after chemotherapy and tamoxifen therapy in patients with breast cancer evaluated by optical coherence tomography

British Journal of Dermatology

Volumn 167, Issue 6, 2012, Pages 1272-1278

  Lindner, J ^a   Hillmann, K ^b   Blume Peytavi, U ^b   Lademann, J ^c   Lux, A ^d   Stroux, A ^e   Schneider, A ^e   Garcia Bartels, N ^b  

^a Department of Dermatology and Allergy ^*  (Germany)

^b Clinical Research Center for Hair and Skin Science   (Germany)

^c Center of Experimental and Applied Cutaneous Physiology   (Germany)

^d OTTO VON GUERICKE UNIVERSITY   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; PACLITAXEL; TAMOXIFEN; TRASTUZUMAB;

ADULT; AGED; ALOPECIA; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HAIR ANALYSIS; HAIR DISEASE; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; AGED; ALOPECIA; ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HAIR FOLLICLE; HUMANS; MIDDLE AGED; PROSPECTIVE STUDIES; TAMOXIFEN; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84870236881     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.11180.x     Document Type: Article

References (33)

1. Trüeb RM,. Chemotherapy-induced alopecia. Semin Cutan Med Surg 2009; 28: 11-4.
2. Routhouska S, Gilliam AC, Mirmirani P,. Hair depigmentation during chemotherapy with a class III/IV receptor tyrosine kinase inhibitor. Arch Dermatol 2006; 142: 1477-9.
3. Sperling LC,. Hair and systemic disease. Dermatol Clin 2001; 19: 711-26, ix.
4. Garcia Bartels N, Jahnke I, Patzelt A, et al. Hair shaft abnormalities in alopecia areata evaluated by optical coherence tomography. Skin Res Technol 2011; 17: 201-5.
5. Kozlowska U, Blume-Peytavi U, Kodelja V, et al. Expression of vascular endothelial growth factor (VEGF) in various compartments of the human hair follicle. Arch Dermatol Res 1998; 290: 661-8.
6. Williamson PJ, de Berker D,. Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease. Br J Haematol 2005; 128: 582.
7. Botchkarev VA,. Molecular mechanisms of chemotherapy-induced hair loss. J Investig Dermatol Symp Proc 2003; 8: 72-5.
8. Yun SJ, Kim SJ,. Hair loss pattern due to chemotherapy-induced anagen effluvium: a cross-sectional observation. Dermatology 2007; 215: 36-40.
9. Tosti A, Pazzaglia M,. Drug reactions affecting hair: diagnosis. Dermatol Clin 2007; 25: 223-31, vii.
10. Tosti A, Piraccini BM, Vincenzi C, Misciali C,. Permanent alopecia after busulfan chemotherapy. Br J Dermatol 2005; 152: 1056-8.
11. Puglisi F, Aprile G, Sobrero A,. Tamoxifen-induced total alopecia. Ann Intern Med 2001; 134: 1154-5.
12. Ayoub JP, Valero V, Hortobagyi GN,. Tamoxifen-induced female androgenetic alopecia in a patient with breast cancer. Ann Intern Med 1997; 126: 745-6.
13. Hampson JP, Donnelly A, Lewis-Jones MS, Pye JK,. Tamoxifen-induced hair colour change. Br J Dermatol 1995; 132: 483-4.
14. Birch MP, Messenger JF, Messenger AG,. Hair density, hair diameter and the prevalence of female pattern hair loss. Br J Dermatol 2001; 144: 297-304.
15. Blume-Peytavi U, Vieten J, Knüttel A, et al. Optical coherent tomography (OCT): a new method for online-measurement of hair shaft thickness. J Dtsch Dermatol Ges 2004; 2: 546.
16. Blume-Peytavi U, Hillmann K, Guarrera M,. Hair growth assessment techniques. In: Hair Growth and Disorders (, Blume-Peytavi U, Tosti A, Whiting DA, Trüeb R, eds), 1st edn. Berlin, Heidelberg: Springer-Verlag, 2008; 148-9.
17. Lademann J, Patzelt A, Darvin M, et al. Application of optical non-invasive methods in skin physiology. Laser Phys Lett 2008; 5: 335-46.
18. Lademann J, Shevtsova J, Patzelt A, et al. Optical coherent tomography for in vivo determination of changes in hair cross section and diameter during treatment with glucocorticosteroids-a simple method to screen for doping substances? Skin Pharmacol Physiol 2008; 21: 312 -r 7.
19. Lademann J, Knüttel A, Richter H, et al. Application of optical coherent tomography for skin diagnostics. Laser Phys 2005; 15: 288-94.
20. Lademann J, Shevtsova J, Patzelt A, et al. Optical method for the screening of doping substances. Laser Phys Lett 2008; 5: 908-11.
21. Vogt A, McElwee KJ, Blume-Peytavi U,. Biology of the hair follicle. In: Hair Growth and Disorders (, Blume-Peytavi U, Tosti A, Whiting DA, Trüeb R, eds), 1st edn. Berlin, Heidelberg: Springer-Verlag, 2008; 1-22.
22. Wolfram LJ,. Human hair: a unique physicochemical composite. J Am Acad Dermatol 2003; 48: 106-14.
23. Velasco MVR, Baby AR, Sarruf FD, et al. Prospective ultramorphological characterization of human hair by optical coherence tomography. Skin Res Technol 2009; 15: 440-3.
24. Hrdy D,. Quantitative hair form variation in seven populations. Am J Phys Anthropol 1973; 39: 7-17.
25. Garcia Bartels N, Blume-Peytavi U,. Haaralterung: Klinik, Ursachen und Prävention. In: Hautalterung-Grundlagen, Prävention, Therapie (, Krutmann J, Diepgen T, Billmann-Krutmann C, eds), 2nd edn. Berlin, Heidelberg: Springer-Verlag, 2008; 241-50.
26. Lademann J, Otberg N, Richter H, et al. Application of optical non-invasive methods in skin physiology: a comparison of laser scanning microscopy and optical coherent tomography with histological analysis. Skin Res Technol 2007; 13: 119-32.
27. Garcia Bartels N, Stieler K, Richter H, et al. Optical coherent tomography: promising in vivo measurement of hair shaft cross section. J Biomed Opt 2011; 16: 096003.
28. Valins W, Vega J, Amini S, et al. Alteration in hair texture following regrowth in alopecia areata: a case report. Arch Dermatol 2011; 147: 1297-9.
29. Thibaut S, Gaillard O, Bouhanna P, et al. Human hair shape is programmed from the bulb. Br J Dermatol 2005; 152: 632-8.
30. Shimomura Y, Wajid M, Petukhova L, et al. Autosomal-dominant woolly hair resulting from disruption of keratin 74 (KRT74), a potential determinant of human hair texture. Am J Hum Genet 2010; 86: 632-8.
31. Bleiker TO, Nicolaou N, Traulsen J, Hutchinson PE,. Atrophic telogen effluvium from cytotoxic drugs and randomized controlled trial to investigate the possible protective effect of pretreatment with a topical vitamin D analogue in humans. Br J Dermatol 2005; 153: 103-12.
32. Hesketh PJ, Batchelor D, Golant M, et al. Chemotherapy-induced alopecia: psychosocial impact and therapeutic approaches. Support Care Cancer 2004; 12: 543-9.
33. Wang J, Lu Z, Au JL,. Protection against chemotherapy-induced alopecia. Pharm Res 2006; 23: 2505-14.